Riskpilot← Back to searchSign inGet full accessHälsokraten AB
ABActiveOrg 5592341449Kvillegatan 7General medical practice activities · NACE 8621Est. 20191 employees
Revenue 2025
SEK 279K
+11% vs 2024
EBITDA margin
7.5%
+109% vs 2024
Equity ratio
61.4%
Financial strength
Net profit 2025
SEK 17K
+108% vs 2024
| Revenue | SEK 279K | +11% |
| EBITDA | SEK 21K | +109% |
| Net profit | SEK 17K | +108% |
| Total assets | SEK 146K | -18% |
| Equity | SEK 90K | +71% |
| Employees | 1 | — |
Legal name
Hälsokraten AB
Org number
5592341449
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 december 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget bedriver främst tjänster inom estetik, vård och omsorg. Konsultverksamhet inom vård och estetik. Hyrläkare som bedriver konsultuppdrag inom vården. Bedrivande av estetiska behandlingar privat och som konsult. Äga samt förvalta värdepapper och fastigheter. Arrangemang av utbildningar, kurser och föreläsningar främst inom vård.
Address
Kvillegatan 7
Email
armin.soleimanpor@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 225 | 127 | 612 | 252 | 279 |
| Staff expenses | — | −10 | −99 | −55 | −0 |
| EBITDA | −22 | 46 | 332 | −227 | 21 |
| Depreciation & amort. | −0 | — | −42 | — | — |
| EBIT | −22 | 46 | 290 | −227 | 21 |
| Net financials | — | −0 | 0 | 0 | −4 |
| Profit before tax | −22 | 46 | 290 | −227 | 17 |
| Tax | −0 | — | −60 | — | — |
| Net profit | −22 | 46 | 230 | −227 | 17 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 21 | 77 | 469 | 177 | 146 |
| Equity | 4 | 49 | 280 | 53 | 90 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 17 | 28 | 189 | 125 | 56 |
| Total debt | 17 | 28 | 189 | 125 | 56 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20212025
Equity ratio
61.4%
This company
38.2%
Market median
+61% vs market
20212025
Return on equity
19.2%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20212025
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
20212025
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
YS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
AS Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsokraten AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yosef Soleimanpor | Deputy Chief Executive Officer | 0 companies |
| Armin Soleimanpor | Chief Executive Officer | 0 companies |